LYVE-1 enhances the adhesion of HS-578T cells to COS-7 cells via hyaluronan

Clinical and Investigative Medicine

Volumn 34, Issue 1, 2011, Pages

  Du, Yan ^a   Liu, Yiwen ^a   Wang, Yingzhi ^a   He, Yiqing ^a   Yang, Cuixia ^a   Gao, Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; LYMPHATIC VESSEL ENDOTHELIAL HA RECEPTOR 1 PROTEIN, HUMAN; LYMPHATIC VESSEL ENDOTHELIAL HA RECEPTOR-1 PROTEIN, HUMAN; VESICULAR TRANSPORT PROTEIN;

ANIMAL; ARTICLE; CELL ADHESION; CELL LINE; CELL STRAIN COS1; CERCOPITHECUS; CONFOCAL MICROSCOPY; GENETICS; METABOLISM; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; HYALURONIC ACID; MICROSCOPY, CONFOCAL; VESICULAR TRANSPORT PROTEINS;

EID: 79951716230     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 1991; 324: 1-8.
2. Chu JS, Lee WJ, Chang TC, Chang KJ, Hsu HC. Correlation between tumor angiogenesis and metastasis in breast cancer. J Formos Med Assoc. 1995; 94: 373-8.
3. Kato T, Kameoka S, Kimura T, et al. Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer. Breast Cancer Res Treat. 2001; 70: 65-74. (Pubitemid 33105104)
4. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol. 1995; 177: 275-83.
5. Saleh M, Stacker SA, Wilks AF. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer research. 1996; 56: 393-401. (Pubitemid 26026370)
6. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993; 362: 841-4. (Pubitemid 23132159)
7. Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. The Journal of cell biology. 1999; 144: 789-801. (Pubitemid 29234556)
8. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell. 1999; 98: 769-78. (Pubitemid 29446894)
9. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a speciic marker for lymphatic endothelium. Am J Pathol. 1999; 154: 385-94. (Pubitemid 29094089)
10. Nibbs RJ, Kriehuber E, Ponath PD, et al. The β-chemokine receptor D6 is expressed by lymphatic endothelium and a subset ofvascular tumors. Am J Pathol. 2001; 158: 867-77. (Pubitemid 32221780)
11. Irjala H, Johansson EL, Grenman R, Alanen K, Salmi M, Jalkanen S. Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium. J Exp Med. 2001; 194: 1033-42.
12. Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. 2001; 7: 192-8. (Pubitemid 32148486)
13. Mattila MM, Ruohola JK, Karpanen T, Jackson DG, Alitalo K, Harkonen PL. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer. 2002; 98: 946-51. (Pubitemid 34286696)
14. Zhang L, Underhill CB, Chen L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer research. 1995; 55: 428-33.
15. Itano N, Sawai T, Miyaishi O, Kimata K. Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer research. 1999; 59: 2499-504. (Pubitemid 29242303)
16. Collis L, Hall C, Lange L, Ziebell M, Prestwich R, Turley EA. Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action. FEBS Lett. 1998; 440: 444-9. (Pubitemid 29052331)
17. Evanko SP, Angello JC, Wight TN. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999; 19: 1004-13. (Pubitemid 29177349)
18. Knudson W, Bartnik E, Knudson CB. Assembly of pericellular matrices by COS-7 cells transfected with CD44 lymphocyte-homing receptor genes. Proc Natl Acad Sci U S A. 1993; 90: 4003-7. (Pubitemid 23134154)
19. Simpson MA, Wilson CM, Furcht LT, Spicer AP, Oegema TR, Jr., McCarthy JB. Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells. The Journal of biological chemistry. 2002; 277: 10050-7. (Pubitemid 34968115)
20. Clarris BJ, Fraser JR. On the pericellular zone of some mammalian cells in vitro. Exp Cell Res. 1968; 49: 181-93.
21. Forbes JF. The incidence of breast cancer: the global burden, public health considerations. Semin Oncol. 1997; 24: S1-20-S1-35.
22. Gao F, Lu YM, Cao ML, Liu YW, He YQ, Wang Y. Expression and quantification of LYVE-1 in human colorectal cancer. Clin Exp Med. 2006; 6: 65-71.
23. Cunnick GH, Jiang WG, Gomez KF, Mansel RE. Lymphangiogenesis quantiication using quantitative PCR and breast cancer as a model. Biochem Biophys Res Commun. 2001; 288: 1043-6. (Pubitemid 33140990)
24. Kohda D, Morton CJ, Parkar AA, et al. Solution structure of the link module: a hyaluronan-binding domain involved in extracellular matrix stability and cell migration. Cell. 1996; 86: 767-75. (Pubitemid 26303445)
25. Johnson LA, Prevo R, Clasper S, Jackson DG. Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. The Journal of biological chemistry. 2007; 282: 33671-80. (Pubitemid 350159526)
26. Gale NW, Prevo R, Espinosa J, et al. Normal lymphatic development and function in mice deicient for the lymphatic hyaluronan receptor LYVE-1. Mol Cell Biol. 2007; 27: 595-604. (Pubitemid 46080127)